Chen Zhong-Hua, Jin Shen-Hui, Wang Min-Yan, Jin Xiao-Liang, Lv Chen, Deng Ying-Feng, Wang Jun-Lu
Department of Anesthesiology, Shaoxing People's Hospital and Shaoxing Hospital of Zhejiang University, Shaoxing, People's Republic of China.
Anat Rec (Hoboken). 2015 Apr;298(4):720-6. doi: 10.1002/ar.23059. Epub 2014 Oct 29.
The NACHT, LRR, and PYD domains-containing protein 3 (NLRP3) inflammasome plays an important role in a variety of diseases. However, the role of NLRP3 in the human intervertebral disc (IVD) degeneration remains unknown. In the present study, we assessed the expression levels of the NLRP3 inflammasome and its downstream targets caspase-1 and IL-1β in 45 degenerate and seven nondegenerate IVD samples. The correlation between the degeneration scores and expression levels of NLRP3, caspase-1, and IL-1β were also analyzed. The mRNA expression levels of the three molecules (NLRP3, caspase-1, and IL-1β) were higher in the degenerate IVDs group than the controls (nondegenerate IVDs group). Immunohistochemistry showed that the expression levels of all three molecules were markedly increased in the nucleus pulposus of degenerate IVDs compared with nondegenerate IVDs. There was a positive correlation between the degeneration scores and the expression levels of the NLRP3 inflammasome as well as its downstream targets caspase-1 and IL-1β. The findings suggest that excessive activation of the NLRP3 inflammasome results in overproduction of downstream IL-1β, which participates in the pathogenesis of human IVD degeneration. Therefore, the NLRP3 inflammasome might serve as a potential therapeutic target for the prevention and treatment of IVD degeneration.
含NACHT、LRR和PYD结构域蛋白3(NLRP3)炎性小体在多种疾病中发挥重要作用。然而,NLRP3在人类椎间盘退变中的作用尚不清楚。在本研究中,我们评估了45个退变椎间盘样本和7个非退变椎间盘样本中NLRP3炎性小体及其下游靶点半胱天冬酶-1和白细胞介素-1β的表达水平。还分析了退变评分与NLRP3、半胱天冬酶-1和白细胞介素-1β表达水平之间的相关性。退变椎间盘组中这三种分子(NLRP3、半胱天冬酶-1和白细胞介素-1β)的mRNA表达水平高于对照组(非退变椎间盘组)。免疫组织化学显示,与非退变椎间盘相比,退变椎间盘髓核中所有三种分子的表达水平均显著增加。退变评分与NLRP3炎性小体及其下游靶点半胱天冬酶-1和白细胞介素-1β的表达水平之间存在正相关。这些发现表明,NLRP3炎性小体的过度激活导致下游白细胞介素-1β的过度产生,后者参与了人类椎间盘退变的发病机制。因此,NLRP3炎性小体可能成为预防和治疗椎间盘退变的潜在治疗靶点。